102 related articles for article (PubMed ID: 15698598)
1. A rapid methodology for the isolation of intermediate-density lipoprotein: characterization of lipid composition and apoprotein content.
McFarlane C; Young IS; Hare L; Mahon G; McEneny J
Clin Chim Acta; 2005 Mar; 353(1-2):117-25. PubMed ID: 15698598
[TBL] [Abstract][Full Text] [Related]
2. Development of a lipoprotein profile using capillary electrophoresis and mass spectrometry.
Macfarlane RD; Bondarenko PV; Cockrill SL; Cruzado ID; Koss W; McNeal CJ; Spiekerman AM; Watkins LK
Electrophoresis; 1997 Sep; 18(10):1796-806. PubMed ID: 9372272
[TBL] [Abstract][Full Text] [Related]
3. Effects of the cholesteryl ester transfer protein inhibitor torcetrapib on apolipoprotein B100 metabolism in humans.
Millar JS; Brousseau ME; Diffenderfer MR; Barrett PH; Welty FK; Faruqi A; Wolfe ML; Nartsupha C; Digenio AG; Mancuso JP; Dolnikowski GG; Schaefer EJ; Rader DJ
Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1350-6. PubMed ID: 16574893
[TBL] [Abstract][Full Text] [Related]
4. Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques.
Ose L; Reyes R; Johnson-Levonas AO; Sapre A; Tribble DL; Musliner T
Clin Ther; 2007 Nov; 29(11):2419-32. PubMed ID: 18158082
[TBL] [Abstract][Full Text] [Related]
5. Very low and intermediate density lipoprotein fractions from apolipoprotein E gene-knockout mice induce cholesteryl ester accumulation in J774 macrophages.
Zhang C; Akira M; Hideki H; Hisashi S; Seikoh H
Chin Med J (Engl); 1999 Jun; 112(6):543-5. PubMed ID: 11601335
[TBL] [Abstract][Full Text] [Related]
6. Effect of fenofibrate on plasma lipoprotein composition and kinetics in patients with complete hepatic lipase deficiency.
Ruel IL; Lamarche B; Mauger JF; Badellino KO; Cohn JS; Marcil M; Couture P
Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2600-7. PubMed ID: 16224048
[TBL] [Abstract][Full Text] [Related]
7. Lipoprotein profile in men with peripheral vascular disease. Role of intermediate density lipoproteins and apoprotein E phenotypes.
Sentí M; Nogués X; Pedro-Botet J; Rubiés-Prat J; Vidal-Barraquer F
Circulation; 1992 Jan; 85(1):30-6. PubMed ID: 1728461
[TBL] [Abstract][Full Text] [Related]
8. Lipoprotein physiology.
Ginsberg HN
Endocrinol Metab Clin North Am; 1998 Sep; 27(3):503-19. PubMed ID: 9785050
[TBL] [Abstract][Full Text] [Related]
9. LDL retention time in plasma can be -based on causation- estimated by the lipid composition of LDL and other lipoproteins.
Jansen M; Contini C
PLoS One; 2022; 17(7):e0272050. PubMed ID: 35901111
[TBL] [Abstract][Full Text] [Related]
10. [Relevance of lipoprotein cholesterol levels measured by HPLC method to appearance midband on electrophoresis and remnant-like particle (RLP)-cholesterol levels].
Kurosawa H; Doumitu K; Kobayashi M; Hirowatari Y; Yoshida H; Tada N
Rinsho Byori; 2004 Sep; 52(9):737-41. PubMed ID: 15552933
[TBL] [Abstract][Full Text] [Related]
11. Effect of combination nicotinic acid and gemfibrozil treatment on intermediate density lipoprotein, and subclasses of low density lipoprotein and high density lipoprotein in patients with combined hyperlipidemia.
Superko HR; Garrett BC; King SB; Momary KM; Chronos NA; Wood PD
Am J Cardiol; 2009 Feb; 103(3):387-92. PubMed ID: 19166694
[TBL] [Abstract][Full Text] [Related]
12. Effect of ezetimibe on the in vivo kinetics of apoB-48 and apoB-100 in men with primary hypercholesterolemia.
Tremblay AJ; Lamarche B; Cohn JS; Hogue JC; Couture P
Arterioscler Thromb Vasc Biol; 2006 May; 26(5):1101-6. PubMed ID: 16528005
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein E is a biologically active constituent of the normal immunoregulatory lipoprotein, LDL-In.
Pepe MG; Curtiss LK
J Immunol; 1986 May; 136(10):3716-23. PubMed ID: 3701060
[TBL] [Abstract][Full Text] [Related]
14. Cholesterol profile measurement by vertical auto profile method.
Kulkarni KR
Clin Lab Med; 2006 Dec; 26(4):787-802. PubMed ID: 17110240
[TBL] [Abstract][Full Text] [Related]
15. The role of dietary oxidized cholesterol and oxidized fatty acids in the development of atherosclerosis.
Staprans I; Pan XM; Rapp JH; Feingold KR
Mol Nutr Food Res; 2005 Nov; 49(11):1075-82. PubMed ID: 16270280
[TBL] [Abstract][Full Text] [Related]
16. [Effect of vitamin E supplementation on the vitamin content of lipoprotein in young men and women].
Somogyi A; Herold M; Kocsis I; Nagy G; Somfai G; Studinger P
Orv Hetil; 2005 Aug; 146(35):1813-8. PubMed ID: 16187540
[TBL] [Abstract][Full Text] [Related]
17. Delayed in vivo catabolism of intermediate-density lipoprotein and low-density lipoprotein in hemodialysis patients as potential cause of premature atherosclerosis.
Ikewaki K; Schaefer JR; Frischmann ME; Okubo K; Hosoya T; Mochizuki S; Dieplinger B; Trenkwalder E; Schweer H; Kronenberg F; Koenig P; Dieplinger H
Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2615-22. PubMed ID: 16195474
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein-B subclasses as acceptors of cholesteryl esters transferred by CETP.
Lee DM; Alaupovic P; Knight-Gibson C; Bagdade JD
Eur J Clin Invest; 2008 Oct; 38(10):734-42. PubMed ID: 18761668
[TBL] [Abstract][Full Text] [Related]
19. [Remnant lipoprotein cholesterol level measured by homogeneous assay reflects the quantity of intermediate-density lipoprotein].
Murano T; Kiuchi M; Moteki M; Miyashita Y; Watanabe H; Hiruta N; Shirai K
Rinsho Byori; 2008 May; 56(5):367-72. PubMed ID: 18546884
[TBL] [Abstract][Full Text] [Related]
20. Lipoprotein-like particles and cholesteryl esters in human Bruch's membrane: initial characterization.
Li CM; Chung BH; Presley JB; Malek G; Zhang X; Dashti N; Li L; Chen J; Bradley K; Kruth HS; Curcio CA
Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2576-86. PubMed ID: 15980251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
